Sehested M, Skovsgaard T, van Deurs B, Winther-Nielsen H
Institute of Pathological Anatomy, University of Copenhagen, Herlev Hospital, Denmark.
Br J Cancer. 1987 Dec;56(6):747-51. doi: 10.1038/bjc.1987.282.
Numerous studies have indicated that the plasma membrane plays an important role in the development of resistance to anthracycline and vinca alkaloid drugs (pleiotropic resistance). We have previously shown that pleiotropically resistant Ehrlich ascites tumour cells, which are of epithelial origin, have a significantly increased plasma membrane traffic (endo/exocytosis) to the endosomal compartment compared to sensitive cells. The present study, using the same ultrastructural morphometric technique, has demonstrated a similar significant difference in plasma membrane traffic between daunorubicin resistant and sensitive P388 cell lines (which are of lymphoid origin). Furthermore, we have shown that this difference between the P388 sublines is accompanied by an approximately 4 fold increase in the plasma membrane area participating in recycling together with an increased endosomal volume, number and membrane area in resistant cells. Plasma membrane traffic in resistant cells was significantly inhibited by the calcium channel blocker verapamil, a well known modulator of anthracycline resistance, but unaffected by daunorubicin itself. The confirmation of this phenotype in an additional pleiotropically resistant cell type with a different histogenesis further supports a hypothesis of endosomal drug trapping and vesicular extrusion as a possible resistance mechanism.
众多研究表明,质膜在对蒽环类药物和长春花生物碱类药物的耐药性发展(多药耐药)中发挥着重要作用。我们之前已经表明,与敏感细胞相比,源自上皮的多药耐药艾氏腹水瘤细胞向内体区室的质膜转运(内吞/外排)显著增加。本研究使用相同的超微结构形态计量技术,证明了柔红霉素耐药和敏感的P388细胞系(源自淋巴)之间在质膜转运方面也存在类似的显著差异。此外,我们还表明,P388亚系之间的这种差异伴随着参与再循环的质膜面积增加约4倍,以及耐药细胞内体体积、数量和膜面积的增加。耐药细胞中的质膜转运受到钙通道阻滞剂维拉帕米的显著抑制,维拉帕米是一种众所周知的蒽环类耐药调节剂,但不受柔红霉素本身的影响。在另一种具有不同组织发生的多药耐药细胞类型中证实这种表型,进一步支持了内体药物捕获和囊泡外排作为一种可能的耐药机制的假说。